Skip to main content

Table 1 Clinicopathological parameters of patients, with respectively good and bad outcome

From: Molecular markers associated with outcome and metastasis in human pancreatic cancer

Category

Gender

Age

Location

pG

pT

pN

pM

pR

PNI

LVI

VI

Postop

OS

DFS

GOOD

F

55

Head

2

2

0

0

0

1

0

1

0

156.4

156.4

GOOD

M

32

Head

3

3

1

0

0

1

1

0

RCT

127.9

127.9

GOOD

M

78

Head

1

3

0

0

0

0

1

0

0

71.5

71.5

GOOD

M

53

Head

3

3

1

0

0

1

0

1

RCT

67.2

67.2

GOOD

F

61

Head

3

3

0

0

0

1

0

1

0

56.4

56.4

GOOD

F

62

Head

3

3

1

0

0

0

0

1

RCT

62.7

62.7

GOOD

M

68

Tail

3

2

0

0

0

1

0

1

CT

51.5

51.5

BAD

F

75

Head

3

3

0

0

0

1

0

0

0

9.4

5.2

BAD

M

72

Head

2

3

1

0

0

1

1

1

CT

12.6

5.6

BAD

M

52

Head

3

3

0

0

0

1

0

1

0

8.4

4.1

BAD

F

78

Head

2

3

1

0

0

1

1

1

0

9.9

3.6

BAD

M

59

Head

3

3

1

0

0

1

0

0

0

6.3

2.8

BAD

F

51

Head

3

3

0

0

0

0

0

0

CT

19.4

6.5

BAD

M

74

Tail

3

1

1

0

0

1

1

1

CT

12.3

0.5

BAD

M

50

Head

2

2

1

0

0

1

1

1

CT

9.4

7.0

BAD(M)

M

67

Head

   

1

    

CT

8.3

/

  1. F: female; M: male; pG: pathological tumour grade; pT: pathological tumour size; pN: pathological lymph node status; pM: pathological metastasis; pR: pathological resection margin; PNI: perineural invasion; VI: vascular invasion; LVI: lymphovascular invasion; RCT: radiochemotherapy; CT: chemotherapy; OS: overall survival; DFS: disease-free survival.